Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus

ConclusionOur data reveal that chain-length specific ceramides in blood, most likely C24:1Cer levels in serum, could act as potent biomarkers for renal impairment in patients suffering from SLE.

Source: Prostaglandins and Other Lipid Mediators - July 11, 2019 Category: Lipidology Source Type: research